Results 191 to 200 of about 1,986,272 (219)

Human Induced Pluripotent Stem Cells in Rare Neurological Disorders: Opportunities and Challenges for Disease Modeling and Drug Discovery. [PDF]

open access: yesStem Cells Int
Harej Hrkać A   +8 more
europepmc   +1 more source

Salmonella enterica serovar typhi limits the potency of typhoid toxin and ADP‐ribosylating toxin AB to establish a persistent infection

open access: yesFEBS Open Bio, EarlyView.
The two catalytic subunits of typhoid toxin dissociate from the holotoxin in the ER of an intoxicated cell, but only CdtB exits the ER to generate immunosuppressive effects. PltA is retained in the ER and sequestered from its cytosolic target, thus allowing the anti‐inflammatory effects of CdtB to promote intestinal colonization.
Maria C. Zabala‐Rodriguez   +4 more
wiley   +1 more source

Organoids and organs-on-a-chip as new approach methodologies at the convergence of cell biology and bioengineering. [PDF]

open access: yesCell Stem Cell
Tavakol DN   +4 more
europepmc   +1 more source

Cell surface CD11c as a neutrophil aging marker molecule

open access: yesFEBS Open Bio, EarlyView.
Cell surface CD11chi neutrophils were more aged and had better phagocytic function than CD11c−/lo neutrophils. Transcriptomic analysis of CD11chi neutrophils and CD11c−/lo neutrophils in pediatric population showed that the most difference was seen in infants.
Sophia Koutsogiannaki   +5 more
wiley   +1 more source

Theratyping for personalized medicine across cystic fibrosis disease models. [PDF]

open access: yesCommun Med (Lond)
Bezzerri V   +8 more
europepmc   +1 more source

Preclinical models of COPD: a state of the art review. [PDF]

open access: yesEur Respir J
Polverino F   +14 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Epigenetics: Future Prospective in Human Disorders and Therapeutics

Medical Epigenetics, 2021
Shriram N Rajpathak
exaly  

Home - About - Disclaimer - Privacy